Pancreatic tumor cells release large amounts of a protein called Tissue Factor into the bloodstream. This protein functions as the body’s primary “emergency trigger” for blood clotting, initiating the coagulation cascade—the complex sequence of reactions that ultimately forms a clot.
In addition, cancer cells shed microscopic particles containing Tissue Factor into circulation. These particles travel throughout the bloodstream, spreading clot-promoting signals to distant areas of the body. They frequently lodge in the legs, where clot formation often occurs.
Adenocarcinoma Mucins
Another important contributor involves mucins—large, sugar-coated proteins produced by many pancreatic tumors. When these mucins enter the bloodstream, they behave like adhesive bridges, attaching to platelets and white blood cells. This interaction activates them in ways that strongly encourage clot formation, as described in research published in the Journal of Mind and Medical Science.
Together, these mechanisms create what physicians sometimes refer to as “sticky blood”—a condition in which the body’s natural clotting system remains continuously activated, making it far more likely for dangerous blockages to form.
